Trial Profile
A multicentre, observational safety and efficacy trial of single tablet regimen rilpivirine-tenofovir-emtricitabine (Elviplera) in clinical practice: experience from the UK and Ireland
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Dec 2015
Price :
$35
*
At a glance
- Drugs Emtricitabine/rilpivirine/tenofovir disoproxil fumarate (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions
- 06 Dec 2015 New trial record